drugset / Trial / NCT00102700
ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The study will document the safety and efficacy of the combination of ARQ 501 and gemcitabine in patients with treatment-naïve, unresectable, metastatic pancreatic adenocarcinoma.
Timeline
- Start
- 2005-01
- Primary completion
- 2007-01
- Completion
- 2007-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LAPACHONE | Small molecule | — | — |
| Background | Gemcitabine | Small molecule | — | — |